Citation Impact
Citing Papers
Generation of ordered protein assemblies using rigid three-body fusion
2021 StandoutNobel
Identification of the Cell-Intrinsic and -Extrinsic Pathways Downstream of EGFR and IFNγ That Induce PD-L1 Expression in Head and Neck Cancer
2015
Topological control of cytokine receptor signaling induces differential effects in hematopoiesis
2019 StandoutScienceNobel
An enzymatic toolkit for selective proteolysis, detection, and visualization of mucin-domain glycoproteins
2020 StandoutNobel
A split, conditionally active mimetic of IL-2 reduces the toxicity of systemic cytokine therapy
2022 StandoutNobel
Use of mass media campaigns to change health behaviour
2010 Standout
Cancer Invasion and the Microenvironment: Plasticity and Reciprocity
2011 Standout
The Worldwide Prevalence of ADHD: A Systematic Review and Metaregression Analysis
2007 Standout
Matrix metalloproteinases and the regulation of tissue remodelling
2007 Standout
Lumacaftor–Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508delCFTR
2015 Standout
Oncology Meets Immunology: The Cancer-Immunity Cycle
2013 Standout
Does low self-esteem predict depression and anxiety? A meta-analysis of longitudinal studies.
2012 Standout
Combining immunotherapy and targeted therapies in cancer treatment
2012
Sensing extracellular matrix: An update on discoidin domain receptor function
2006
NF-κB in cancer: from innocent bystander to major culprit
2002 Standout
Cellular senescence in aging and age-related disease: from mechanisms to therapy
2015 Standout
Wound repair and regeneration
2008 StandoutNature
Understanding the tumor immune microenvironment (TIME) for effective therapy
2018 Standout
A Comparison of the Neuropsychological Profiles of the DSM-IV Subtypes of ADHD
2001
Cancer immunotherapy via dendritic cells
2012 Standout
Trial watch
2013
Executive function in preschoolers: A review using an integrative framework.
2008 Standout
EGF–ERBB signalling: towards the systems level
2006 Standout
Keratinocyte-derived growth factors play a role in the formation of hypertrophic scars
2001
Synergistic upregulation of metalloproteinase‐9 by growth factors and inflammatory cytokines: an absolute requirement for transcription factor NF‐κB
1998
Antibody therapy of cancer
2012 Standout
Matrix Metalloproteinase-3 Releases Active Heparin-binding EGF-like Growth Factor by Cleavage at a Specific Juxtamembrane Site
1997
Resistance Mechanisms to Immune-Checkpoint Blockade in Cancer: Tumor-Intrinsic and -Extrinsic Factors
2016
Organization of fibroblasts in the heart
2004
Matrix Metalloproteinases: Regulators of the Tumor Microenvironment
2010 Standout
Regulation and Function of the PD-L1 Checkpoint
2018 Standout
Targeting Epidermal Growth Factor Receptor in Head and Neck Cancer
2022
Molecular mechanisms of T cell co-stimulation and co-inhibition
2013 Standout
Interleukin-1 beta targeted therapy for type 2 diabetes
2009
Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy
2017 Standout
Temperament and Attention Deficit Hyperactivity Disorder: The Development of a Multiple Pathway Model
2004
The blockade of immune checkpoints in cancer immunotherapy
2012 Standout
Mental health of young people: a global public-health challenge
2007 Standout
Validity of the Executive Function Theory of Attention-Deficit/Hyperactivity Disorder: A Meta-Analytic Review
2005 Standout
The Inflammasomes
2010 Standout
Collagen I Induces Discoidin Domain Receptor (DDR) 1 Expression through DDR2 and a JAK2-ERK1/2-mediated Mechanism in Primary Human Lung Fibroblasts
2011
Bone marrow stromal cells attenuate sepsis via prostaglandin E2–dependent reprogramming of host macrophages to increase their interleukin-10 production
2008 Standout
Biomarkers for epithelial-mesenchymal transitions
2009 Standout
Fibroblasts in cancer
2006 Standout
The Structure of Child and Adolescent Psychopathology: Generating New Hypotheses.
2004
Combining the Specific Anti-MUC1 Antibody TAB004 and Lip-MSA-IL-2 Limits Pancreatic Cancer Progression in Immune Competent Murine Models of Pancreatic Ductal Adenocarcinoma
2019
Microenvironmental regulation of tumor progression and metastasis
2013 Standout
Inflammasomes: mechanism of action, role in disease, and therapeutics
2015 Standout
Extracellular vesicles: biology and emerging therapeutic opportunities
2013 Standout
Expression of Matrix Metalloproteinases 2 and 9 in Regenerating Skeletal Muscle: A Study in Experimentally Injured andmdxMuscles
1999
Engineered IL-21 Cytokine Muteins Fused to Anti-PD-1 Antibodies Can Improve CD8+ T Cell Function and Anti-tumor Immunity
2020
Management of Cocaine-Associated Chest Pain and Myocardial Infarction
2008
Immunogenic cell death and DAMPs in cancer therapy
2012 Standout
Monoclonal antibodies targeting IL-1 beta reduce biomarkers of atherosclerosis in vitro and inhibit atherosclerotic plaque formation in Apolipoprotein E-deficient mice
2011
Induction of Immunogenic Apoptosis by Blockade of Epidermal Growth Factor Receptor Activation with a Specific Antibody
2011
Physiological Implications of Hydrogen Sulfide: A Whiff Exploration That Blossomed
2012 Standout
Mesenchymal Stem Cell Exosome: a Novel Stem Cell-Based Therapy for Cardiovascular Disease
2011
Extreme stability in de novo-designed repeat arrays is determined by unusually stable short-range interactions
2018 StandoutNobel
Immunotherapy for Colorectal Cancer
2017
Protective effect of hydrogen sulfide in a murine model of acute lung injury induced by combined burn and smoke inhalation
2008
The Inflammasome in Atherosclerosis and Type 2 Diabetes
2011
Designed Ankyrin Repeat Proteins (DARPins): Binding Proteins for Research, Diagnostics, and Therapy
2011
The beyondblue Schools Research Initiative: conceptual framework and intervention
2005
Fetal wound healing
2003
Nanotechnology for Multimodal Synergistic Cancer Therapy
2017 Standout
Longevity of Patients With Cystic Fibrosis in 2000 to 2010 and Beyond: Survival Analysis of the Cystic Fibrosis Foundation Patient Registry
2014
National Institutes of Health Consensus Development Conference Statement: Diagnosis and Treatment of Attention-Deficit/Hyperactivity Disorder (ADHD)
2000
Fiber Types in Mammalian Skeletal Muscles
2011 Standout
Tumor Antigen–Targeted, Monoclonal Antibody–Based Immunotherapy: Clinical Response, Cellular Immunity, and Immunoescape
2010
Concise Review: Mesenchymal Stem Cells: Their Phenotype, Differentiation Capacity, Immunological Features, and Potential for Homing
2007 Standout
Molecular Determinants of T Cell Epitope Recognition to the Common Timothy Grass Allergen
2010
Better Mental Health Services for Young People: Responsibility, Partnerships and Projects
2001
Regulatory T Cells in the Tumor Microenvironment and Cancer Progression: Role and Therapeutic Targeting
2016
Wound Healing: A Cellular Perspective
2018 Standout
Precision glycocalyx editing as a strategy for cancer immunotherapy
2016 StandoutNobel
Reactive Oxygen Species (ROS)-Based Nanomedicine
2019 Standout
Satellite Cells and the Muscle Stem Cell Niche
2013 Standout
Interleukin-1β mediates macrophage-induced impairment of insulin signaling in human primary adipocytes
2014
Reactive oxygen species generating systems meeting challenges of photodynamic cancer therapy
2016 Standout
2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes
2014 Standout
Regulatory T cells expressing abundant CTLA‐4 on the cell surface with a proliferative gene profile are key features of human head and neck cancer
2018 StandoutNobel
initial development of an auditory continuous performance test for preschoolers
2001
Role of Extracellular Matrix in Adaptation of Tendon and Skeletal Muscle to Mechanical Loading
2004 Standout
Regulation of Wound Healing by Growth Factors and Cytokines
2003 Standout
Immunogenic Cell Death in Cancer Therapy
2012 Standout
Recombinant immunotoxin for cancer treatment with low immunogenicity by identification and silencing of human T-cell epitopes
2014 StandoutNobel
Differences Between ADHD Inattentive and Combined Types on the CPT
2003
Preventive Interventions Addressing Underage Drinking: State of the Evidence and Steps Toward Public Health Impact
2008
Works of Steve Lee being referenced
Cetuximab-Activated Natural Killer and Dendritic Cells Collaborate to Trigger Tumor Antigen–Specific T-cell Immunity in Head and Neck Cancer Patients
2013
Airway House Dust Extract Exposures Modify Allergen-Induced Airway Hypersensitivity Responses by TLR4-Dependent and Independent Pathways
2008
Combined burn and smoke inhalation injury impairs ovine hypoxic pulmonary vasoconstriction*
2006
Validity of DSM‐IV Attention‐Deficit/Hyperactivity Disorder for Younger Children
1998
Intravenous mesenchymal stem cell therapy early after reperfused acute myocardial infarction improves left ventricular function and alters electrophysiologic properties
2005
Discoidin Domain Receptors and Their Ligand, Collagen, Are Temporally Regulated in Fetal Rat Fibroblasts in Vitro
2001
Role of polymorphic Fc gamma receptor IIIa and EGFR expression level in cetuximab mediated, NK cell dependent in vitro cytotoxicity of head and neck squamous cell carcinoma cells
2009
Interleukin-1 and Transforming Growth Factor-α: Synergistic Stimulation of Metalloproteinases, PGE2, and Proliferation in Human Fibroblasts
1994
Differential Expression of Receptor Tyrosine Kinases and Shc in Fetal and Adult Rat Fibroblasts: Toward Defining Scarless versus Scarring Fibroblast Phenotypes
2000
Comparison of frequency of left ventricular wall motion abnormalities in patients with a first acute myocardial infarction with versus without left ventricular hypertrophy
2004
Immunotherapy of head and neck cancer using tumor antigen-specific monoclonal antibodies
2009
Natural killer (NK):dendritic cell (DC) cross talk induced by therapeutic monoclonal antibody triggers tumor antigen-specific T cell immunity
2011
A Partially Parametric Estimator of Survival in the Presence of Randomly Censored Data
1990
CTLA-4+ Regulatory T Cells Increased in Cetuximab-Treated Head and Neck Cancer Patients Suppress NK Cell Cytotoxicity and Correlate with Poor Prognosis
2015
XOMA 052, an Anti-IL-1β Monoclonal Antibody, Improves Glucose Control and β-Cell Function in the Diet-Induced Obesity Mouse Model
2010
Combination between a long-acting engineered cytokine (NKTR-214) and checkpoint inhibitors anti-CTLA-4 or anti-PD1 in murine tumor models.
2014